Patient Perspectives on Treatment Experience and Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Nathwani, Nitya
Bell, Jill A.
Cherepanov, Dasha
Sowell, France Ginchereau
Shah, Rachel
McCarrier, Kelly
Hari, Parameswaran
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-137054
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
    Ludwig, Heinz
    Moreau, Philippe
    Dimopoulos, Meletios A.
    Mateos, Maria-Victoria
    Kaiser, Martin
    Hajek, Roman
    Feng, Shibao
    Cocks, Kim
    Buchanan, Jaqueline
    Weisel, Katja
    [J]. BLOOD CANCER JOURNAL, 2019, 9 (3)
  • [32] Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Schjesvold, Fredrik H.
    Ludwig, Heinz
    Delimpasi, Sossana
    Robak, Pawel
    Coriu, Daniel
    Tomczak, Waldemar
    Pour, Ludek
    Spicka, Ivan
    Dimopoulos, Meletios-Athanasios
    Masszi, Tamas
    Chernova, Natalia G.
    Sandberg, Anna
    Thuresson, Marcus
    Norin, Stefan
    Bakker, Nicolaas A.
    Mateos, Maria-Victoria
    Richardson, Paul G.
    Sonneveld, Pieter
    [J]. REVISTA CHILENA DE LITERATURA, 2024, (109): : 2331 - 2336
  • [33] Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Schjesvold, Fredrik H.
    Ludwig, Heinz
    Delimpasi, Sossana
    Robak, Pawel
    Coriu, Daniel
    Tomczak, Waldemar
    Pour, Ludek
    Spicka, Ivan
    Dimopoulos, Meletios-Athanasios
    Masszi, Tamas
    Chernova, Natalia G.
    Sandberg, Anna
    Thuresson, Marcus
    Norin, Stefan
    Bakker, Nicolaas A.
    Mateos, Maria-Victoria
    Richardson, Paul G.
    Sonneveld, Pieter
    [J]. HAEMATOLOGICA, 2024, 109 (07) : 2331 - 2336
  • [34] Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
    Heinz Ludwig
    Philippe Moreau
    Meletios A. Dimopoulos
    Maria-Victoria Mateos
    Martin Kaiser
    Roman Hajek
    Shibao Feng
    Kim Cocks
    Jaqueline Buchanan
    Katja Weisel
    [J]. Blood Cancer Journal, 9
  • [35] REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Cubillas, Garcia de la Torre Damian
    Inigo, Rodriguez Belen
    Alfayate, Lobo Ana
    Menendez, Cuevas Marina
    Bolanos, Calderon Estefania
    Medina, Salazar Sissy Fiorella
    Mateo, Morales Marta
    Pena, Cortijo Ascension
    Perez, Lopez Cristina
    Polo, Zarzuela Marta
    Calo, Perez Aida
    Colas, Lahuerta Blanca
    Gomez, Alvarez Miguel
    Escribano, Serrat Silvia
    Estival, Monteliu Pablo
    Gulino, Horacio
    Daorta, Melisa
    Moreno, Paredes Nahir Daniela
    Benavente, Cuesta Celina
    [J]. HAEMATOLOGICA, 2020, 105 : 151 - 151
  • [36] Health-related quality of life in multiple myeloma in Kurdistan Iraq
    Badi, Ameer
    Al-Allawi, Nasir
    Yassin, Ahmed
    Safar, Banaz
    Abdulla, Basil
    Shamoon, Rawand
    Amin, Truska
    Mohamed, Zeki
    Mohammed, Ali
    Hussein, Diveen
    Hasan, Kawa
    Mohammed, Nawsherwan
    Rajab, Rezhin
    Hiwaizi, Friad
    Karim, Kanar
    Hassan, Abid
    Getta, Hisham
    Khoshnaw, Najmaddin
    Jalal, Sana
    Mohammed, Akram
    Abdullah, Dana
    [J]. IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (02) : 101 - 106
  • [37] Health-Related Quality of Life in Multiple Myeloma in Kurdistan, Iraq
    Ibrahim, Ameer
    Al-Allawi, Nasir
    Yassin, Ahmed
    Safar, Banaz
    Abdulla, Basil
    Shamoon, Rawand
    Amin, Truska
    Mohamed, Zeki
    Mohammed, Ali
    Hussein, Diveen
    Hasan, Kawa
    Mohammed, Nawsherwan
    Rajab, Rezhin
    Hiwaizi, Friad
    Karim, Kanar
    Hassan, Abid
    Getta, Hisham
    Khoshnaw, Najmaddin
    Jalal, Sana
    Mohammed, Akram
    Abdullah, Dana
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S409 - S409
  • [38] Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO.
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Delimpasi, Sosana
    Beksac, Meral
    Katodritou, Eirini
    Moreau, Philippe
    Baldini, Luca
    Symeonidis, Argiris
    Bila, Jelena
    Oriol, Albert
    Mateos, Maria-Victoria
    Einsele, Hermann
    Orfanidis, Ioannis
    Gries, Katharine S.
    Fastenau, John
    Kampfenkel, Tobias
    Qiu, Yanping
    Amin, Himal
    Sonneveld, Pieter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma
    Otero, Paula Rodriguez
    Towle, Kevin
    Cope, Shannon
    Caisip, Clyde
    Davies, Faith E.
    Delforge, Michel
    Weisel, Katja
    Marshall, Thomas S.
    Karampampa, Korinna
    Ayers, Dieter
    Mojebi, Ali
    Braverman, Julia
    Farrell, James
    Dhanda, Devender
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1864 - 1869
  • [40] Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment data
    Katja Weisel
    Heinz Ludwig
    Achim Rieth
    Andrea Lebioda
    Hartmut Goldschmidt
    [J]. Quality of Life Research, 2020, 29 : 69 - 79
12345